Burning Rock Biotech (BNR) Stock
Burning Rock Biotech (BNR) closed at $13.32 on Nov 19, 2026; its Tenet Score is 42 of 100 against 341 Healthcare peers.
36 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $13.32
- Nov 19, 2026
- 52-week range
- 6.79 – 41.72
- low → high · as of close, Nov 19, 2026
- Tenet Score
- 42/100
- Weak · 341 Healthcare peers
Industry: Health Services
Burning Rock Biotech Ltd scores 42/100. Weak. Growth is the soft spot versus 341 Healthcare peers. Insufficient inputs: Tenet 42 is built from 3 of 4 pillars, from 50% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=341Factor grades
Value omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✓ Reversal Evidence
- ✕ Quality Floor
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer ty…
Common questions
What sector and industry is Burning Rock Biotech in?
Burning Rock Biotech is in the Healthcare sector and the Health Services industry.
What is Burning Rock Biotech's Tenet Score?
Burning Rock Biotech's Tenet Score is 42 out of 100, ranked against 341 Healthcare peers as of Nov 19, 2026.




